Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Sleight

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|February 26, 1991
Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivityM A Harrington, A J Sleight, J Pitha, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1991
Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonistL M Liau, A J Sleight, J Pitha, et al.
Neuroscience|January 1, 1990
In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolismF Crespi, J C Garratt, A J Sleight, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Serotonin receptor "families" in the central nervous system: an overviewS J Peroutka, A W Schmidt, A J Sleight, et al.
British Journal of Pharmacology|February 1, 1988
Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophanA J Sleight, C A Marsden, K F Martin, et al.
Neuropharmacology|May 1, 1989
The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivoA J Sleight, R J Smith, C A Marsden, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding siteF G Boess, F J Monsma, A Bourson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotidesA Bourson, E Borroni, R H Austin, et al.
Molecular Pharmacology|September 1, 1997
Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptorF G Boess, F J Monsma, V Meyer, et al.
Behavioural Brain Research|January 1, 1996
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotidesA J Sleight, F J Monsma, E Borroni, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|February 26, 1991
Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivityM A Harrington, A J Sleight, J Pitha, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1991
Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonistL M Liau, A J Sleight, J Pitha, et al.
Neuroscience|January 1, 1990
In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolismF Crespi, J C Garratt, A J Sleight, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Serotonin receptor "families" in the central nervous system: an overviewS J Peroutka, A W Schmidt, A J Sleight, et al.
British Journal of Pharmacology|February 1, 1988
Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophanA J Sleight, C A Marsden, K F Martin, et al.
Neuropharmacology|May 1, 1989
The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivoA J Sleight, R J Smith, C A Marsden, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding siteF G Boess, F J Monsma, A Bourson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotidesA Bourson, E Borroni, R H Austin, et al.
Molecular Pharmacology|September 1, 1997
Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptorF G Boess, F J Monsma, V Meyer, et al.
Behavioural Brain Research|January 1, 1996
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotidesA J Sleight, F J Monsma, E Borroni, et al.
Pageof 4